Genetics of the Adrenal Gland

Reviews in Endocrine and Metabolic Disorders

Volumn 5, Issue 1, 2004, Pages 53-68

  Stratakis, Constantine A ^a   Bossis, Ioannis ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Adrenal; Adrenocortical cancer; Adrenocortical insufficiency; Congenital adrenocortical hyperplasia; Cortex; Cushing syndrome; Medulla; Molecular genetics; Pheochromocytoma

Indexed keywords

ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX INSUFFICIENCY; ADRENAL GLAND; ADRENAL MEDULLA; CONGENITAL ADRENAL HYPERPLASIA; HUMAN; MOLECULAR GENETICS; PHEOCHROMOCYTOMA; REVIEW;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; 3-HYDROXYSTEROID DEHYDROGENASES; ADRENAL GLAND DISEASES; ADRENAL GLANDS; ADRENAL HYPERPLASIA, CONGENITAL; ADRENAL INSUFFICIENCY; ALDOSTERONE; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; HUMANS; HYDROCORTISONE; STEROID 17-ALPHA-HYDROXYLASE; STEROID 21-HYDROXYLASE;

EID: 1642335537     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:REMD.0000016124.44064.8f     Document Type: Review

References (52)

1. Stratakis CA, Rennert OM. Congenital Adrenal Hyperplasia: Molecular genetics and alternative approaches to treatment [review]. Critical Reviews in Clinical Laboratory Sciences 1999;36:329-363.
2. Mesiano S, Jaffe RB. Developmental and functional biology of the primate fetal adrenal cortex [review]. Endocr Rev 1997;18:378-403.
3. Keegan CE, Hammer GD. Recent insights into organogenesis of the adrenal cortex [review]. Trends Endocrinol Metab 2002;13:200-208.
4. Lee SB, Haber DA. Wilms tumor and the WT1 gene [review]. Exp Cell Res 2001;264:74-99.
5. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R. WT-1 is required for early kidney development. Cell 1993;74:679-691.
6. Vainio S, Heikkila M, Kispert A, Chin N, McMahon AP. Female development in mammals is regulated by Wnt-4 signalling. Nature 1999;397:405-409.
7. Jordan BK, Mohammed M, Ching ST, Delot E, Chen XN, Dewing P, Swain A, Rao PN, Elejalde BR, Vilain E. Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans. Am J Hum Genet 2001;68:1102-1109.
8. Luo X, Ikeda Y, Parker KL. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994;77:481-490.
9. Yu RN, Ito M, Saunders TL, Camper SA, Jameson JL. Role of Ahch in gonadal development and gametogenesis. Nat Genet 1998;20:353-357.
10. Clark AJ, Weber A. Adrenocorticotropin insensitivity syndromes [review]. Endocr Rev 1998;19:828-843.
11. Lewis DFV, Watson E, Lake BG. Evolution of the cytochrome P450 superfamily: Sequence alignmentes and pharmacogenetics. Mutation Res 1998;410:245-270.
12. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC, Nebert DW. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature [review]. Pharmacogenetics 1996;6:1-42.
13. Ishimura K, Fujita H. Light and electron microscopic immunohistochemistry of the localization of adrenal steroidogenic enzymes [review]. Microsc Res Tech 1997;36:445-453.
14. Bose HS, Sugawara T, Strauss JF 3rd, Miller WL. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. International Congenital Lipoid Adrenal Hyperplasia Consortium [review]. N Engl J Med 1996;335:1870-1878.
15. Eisenhofer G, Bornstein ME, Borstein SR. The adrenal medulla, physiology and pathophysiology. In: Handbook of the Autonomic Nervous System in Health and Disease, Marcel Dekker, Inc, 2002;185-224.
16. Pang S, Yang X, Wang M, Tissot R, Nino M, Manaligod J, Bullock LP, Mason JI. Inherited congenital adrenal hyperplasia in the rabbit: Absent cholesterol side-chain cleavage cytochrome P450 gene expression. Endocrinology 1992;131:181-186.
17. Wang X, Liu Z, Eimerl S, Timberg R, Weiss AM, Orly J, Stocco DM. Effect of truncated forms of the steroidogenic acute regulatory protein on intramitochondrial cholesterol transfer. Endocrinology 1998;139:3903-3912.
18. Lin D, Sugawara T, Strauss JF 3rd, Clark BJ, Stocco DM, Saenger P, Rogol A, Miller WL. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 1995;267:1828-1831.
19. Nakae J, Tajima T, Sugawara T, Arakane F, Hanaki K, Hotsubo T, Igarashi N, Igarashi Y. Ishii T, Koda N, Kondo T, Kohno H, Nakagawa Y, Tachibana K, Takeshima Y, Tsubouchi K, Strauss JF 3rd, Fujieda K. Analysis of the steroidogenic acute regulatory protein (StAR) gene in Japanese patients with congenital lipoid adrenal hyperplasia. Hum Mol Genet 1997;6:571-576.
20. Miller WL. Congenital lipoid adrenal hyperplasia: The human gene knockout for the steroidogenic acute regulatory protein. J Mol Endocrinol 1997;19:227-240.
21. Fujieda K, Tajima T, Nakae J, Sageshima S, Tachibana K, Suwa S, Sugawara T, Strauss JF 3rd. Spontaneous puberty in 46,XX subjects with congenital lipoid adrenal hyperplasia. Ovarian steroidogenesis is spared to some extent despite inactivating mutations in the steroidogenic acute regulatory protein (StAR) gene. J Clin Invest 1997;99:1265-1271.
22. Arakane F, King SR, Du Y, Kallen CB, Walsh LP, Watari H, Stocco DM, Strauss JF 3rd. Phosphorylation of steroidogenic acute regulatory protein (StAR) modulates its steroidogenic activity. J Biol Chem 1997;272:32656-32662.
23. Sugawara T, Kiriakidou M, McAllister JM, Holt JA, Arakane F, Strauss JF 3rd. Regulation of expression of the steroidogenic acute regulatory protein (StAR) gene: A central role for steroidogenic factor 1. Steroids 1997;62:5-9.
24. Caron KM, Soo SC, Wetsel WC, Stocco DM, Clark BJ, Parker KL. Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. Proc Natl Acad Sci USA 1997;94:11540-11545.
25. Simard J, Moisan AM, Morel Y. Congenital adrenal hyperplasia due to 3beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase deficiency [review]. Semin Reprod Med 2002;20:255-276.
26. Lutfallah C, Wang W, Mason JI, Chang YT, Haider A, Rich B, Castro-Magana M, Copeland KC, David R, Pang S. Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency [review]. J Clin Endocrinol Metab 2002;87:2611-2622.
27. Biglieri EG. 17 alpha-Hydroxylase deficiency [review]. J Clin Endocrinol Metab 1997;82(1):48-50.
28. Miller WL, Auchus RJ, Geller DH. The regulation of 17,20 lyase activity [review]. Steroids 1997;62:133-142.
29. Zachmann M. Prismatic cases: 17,20-desmolase (17,20-lyase) deficiency [review]. J Clin Endocrinol Metab 1996;81:457-459.
30. Geller DH, Auchus RJ, Mendonca BB, Miller WL. The genetic and functional basis of isolated 17,20-lyase deficiency [review]. Nat Genet 1997;17:201-205.
31. White PC, Curnow KM, Pascoe L. Disorders of steroid 11 beta-hydroxylase isozymes [review]. Endocr Rev 1994;15:421-438.
32. Merke DP, Tajima T, Chhabra A, Barnes K, Mancilla E, Baron J, Cutler GB Jr. Novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11 beta-hydroxylase deficiency. J Clin Endocrinol Metab 1998;83:270-273.
33. Rumsby G, Honour JW. Genetics of adrenal steroid biosynthesis. In: Thakker RV, ed. Molecular Genetics of Endocrine Disorders, London: Chapman & Hall, 1997:263-278.
34. Merke DP, Bornstein SR, Avila NA, Chrousos GP. NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency [review]. Ann Intern Med 2002;136:320-334.
35. Tajima T, Fujieda K, Kouda N, Nakae J, Miller WL. Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency. J Clin Endocrinol Metab 2001;86:3820-3825.
36. Katsumata N, Ohtake M, Hojo T, Ogawa E, Hara T, Sato N, Tanaka T. Compound heterozygous mutations in the cholesterol side-chain cleavage enzyme gene (CYP11A) cause congenital adrenal insufficiency in humans. J Clin Endocrinol Metab 2002;87:3808-3813.
37. Achermann JC, Meeks JJ, Jameson JL. Phenotypic spectrum of mutations in DAX-1 and SF-1 [review]. Mol Cell Endocrinol 2001;185:17-25.
38. Phelan JK, McCabe ER. Mutations in NR0B1 (DAX1) and NR5A1 (SF1) responsible for adrenal hypoplasia congenital [review]. Hum Mutat 2001;18:472-487.
39. Ozisik G, Achermann JC, Meeks JJ, Jameson JL. SF1 in the Development of the Adrenal Gland and Gonads [review]. Horm Res 2003;59(Suppl 1):94-98.
40. Handschug K, Sperling S, Yoon SJ, Hennig S, Clark AJ, Huebner A. Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Hum Mol Genet 2001;10:283-290.
41. Sandrini F, Farmakidis C, Kirschner LS, Wu SM, Tullio-Pelet A, Lyonnet S, Metzger DL, Bourdony CJ, Tiosano D, Chan WY, Stratakis CA. Spectrum of mutations of the AAAS gene in Allgrove syndrome: Lack of mutations in six kindreds with isolated resistance to corticotropin. J Clin Endocrinol Metab 2001;86:5433-5437.
42. Stratakis CA. Cushing syndrome and Addison disease. Hughes IA, Clark AJL (eds). Adrenal Disease in Childhood. Clinical and Molecular Aspects. Endocr Dev. Basel, Karger 2000;2:163-173.
43. Vaidya B, Pearce S, Kendall-Taylor P. Recent advances in the molecular genetics of congenital and acquired primary adrenocortical failure [review]. Clin Endocrinol (Oxf) 2000;53:403-418.
44. Dittmar M, Kahaly GJ. Polyglandular autoimmune syndromes: Immunogenetics and long-term follow-up. J Clin Endocrinol Metab 2003;88:2983-2992.
45. Stratakis CA. Genetics of adrenocortical tumors: Gatekeepers, landscapers and conductors in symphony. Trends Endocrinol Metab 2003;14:404-410.
46. Stratakis CA. Mutations of the gene encoding the protein kinase A type 1-alpha regulatory subunit (PRKAR1A) in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas" (Carney complex) [review]. Ann NY Acad Sci 2002;968:3-21.
47. Bourdeau I, Stratakis CA. Cyclic AMP-dependent signaling aberrations in macronodular adrenal disease [review]. Ann NY Acad Sci 2002;968:240-255.
48. Fragoso MC, Domenice S, Latronico AC, Martin RM, Pereira MA, Zerbini MC, Lucon AM, Mendonca BB. Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J Clin Endocrinol Metab 2003;88:2147-2151.
49. Torpy DJ, Stratakis CA, Chrousos GP. Hyper- and hypoaldosteronism [review]. Vitam Horm 1999;57:177-216.
50. Jackson RV, Lafferty A, Torpy DJ, Stratakis CA. New genetic insights in familial hyperaldosteronism [review]. Ann NY Acad Sci 2002;970:77-88.
51. Koch CA, Pacak K, Chrousos GP. The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors [review]. J Clin Endocrinol Metab 2002;87:5367-5384.
52. Ribeiro RC, Sandrini F, Figueiredo B, Zambetti GP, Michalkiewicz E, Lafferty AR, DeLacerda L, Rabin M, Cadwell C, Sampaio G, Cat I, Stratakis CA, Sandrini R. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci 2001;98:9330-9335.